Clinical evidence for benefit of intracoronary progenitor cell therapy on post-infarction remodeling: Results of the TOPCARE-AMI trial

被引：1
|
作者：
Schachinger, V [1 ]
Assmus, B [1 ]
Lehmann, R [1 ]
Teupe, C [1 ]
Britten, M [1 ]
Doebert, N [1 ]
Martin, H [1 ]
Dimmeler, S [1 ]
Zeiher, AM [1 ]
机构：
[1] Univ Frankfurt, D-6000 Frankfurt, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404A / 404A
页数：1
相关论文
共 50 条
  • [41] Arginine therapy does not benefit children with sickle cell anemia - Results of the CSCC clinical trial consortium multi-institutional study
    Styles, Lori
    Kuypers, Frans
    Kesler, Karen
    Reiss, Ulrike
    Lebeau, Petra
    Nagel, Ronald
    Fabry, Mary
    BLOOD, 2007, 110 (11) : 668A - 668A
  • [42] Results from LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction from the Cardiovascular Cell Therapy Research Network
    Henry, Timothy D.
    Traverse, Jay H.
    Pepine, Carl J.
    Willerson, James T.
    Ellis, Stephen
    Zhao, David X.
    Simpson, Lara
    Perin, Emerson
    Penn, Marc
    Baran, Kenneth W.
    Chambers, Jeffrey
    Lambert, Charles
    Raveendran, Ganesh
    Simon, Daniel
    Gee, Adrian P.
    Forder, John R.
    Taylor, Doris A.
    Cogle, Christopher R.
    Olson, Rachel E.
    Smith, Deirdre
    Geither, Carrie
    Skarlatos, Sonia I.
    Moye, Lemuel A.
    Simari, Robert D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B249 - B249
  • [43] DENDRITIC CELL VACCINATION AS POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA: RESULTS OF A PILOT PHASE I/II CLINICAL TRIAL
    Anguille, S.
    Van Tendeloo, V.
    Van de Velde, A.
    Van Driessche, A.
    Vermeulen, K.
    Pieters, K.
    Nijs, G.
    Stein, B.
    Smits, E.
    Schroyens, W.
    Gadisseur, A.
    Vrelust, I.
    Jorens, P.
    Goossens, H.
    Price, D.
    De Vries, J.
    Oji, Y.
    Oka, Y.
    Sugiyama, H.
    Cools, N.
    Berneman, Z.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S36 - S37
  • [44] Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial
    Woehrle, Jochen
    von Scheidt, Fabian
    Schauwecker, Peter
    Wiesneth, Markus
    Markovic, Sinisa
    Schrezenmeier, Hubert
    Hombach, Vinzenz
    Rottbauer, Wolfgang
    Bernhardt, Peter
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (10) : 765 - 770
  • [45] Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial
    Jochen Wöhrle
    Fabian von Scheidt
    Peter Schauwecker
    Markus Wiesneth
    Sinisa Markovic
    Hubert Schrezenmeier
    Vinzenz Hombach
    Wolfgang Rottbauer
    Peter Bernhardt
    Clinical Research in Cardiology, 2013, 102 : 765 - 770
  • [46] INTRACORONARY STEM CELL THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION-36 MONTHS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL WITH SERIAL MRI FOLLOW-UPS
    Woehrle, Jochen
    von Scheidt, Fabian
    Markovic, Sinisa
    Schauwecker, Peter
    Schwarz, Klaus
    Wiesneth, Markus
    Schrezenmeier, Hubert
    Hombach, Vinzenz
    Rottbauer, Wolfgang
    Bernhardt, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E346 - E346
  • [47] Cell Functionality of Administered Antologous Bone Marrow-Derived Mononuclear Cells Predicts 5-Year Clinical Outcome in Patients with Acute Myocardial Infarction - Results of The REPAIR-AMI Trial
    Assmus, Birgit
    Schaechinqer, Volker
    Erbs, Sandra
    Elsaesser, Albrecht
    Haberbosch, Werner
    Hambrecht, Rainer
    Sedding, Daniel
    Yu, Jiangtao
    Corti, Roberto
    Mathey, Detlef G.
    Hamm, Christian
    Suselbeck, Tim
    Barth, Christine
    Leistner, David M.
    Tonn, Torsten
    Dimmeler, Stefanie
    Zeiher, Andreas M.
    CIRCULATION, 2012, 126 (21)
  • [48] Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial
    Harris, Violaine K.
    Stark, James
    Williams, Armistead
    Roche, Morgan
    Malin, Michaela
    Kumar, Anjali
    Carlson, Alyssa L.
    Kizilbash, Cara
    Wollowitz, Jaina
    Andy, Caroline
    Gerber, Linda M.
    Sadiq, Saud A.
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [49] ONE YEAR FOLLOW-UP RESULTS FROM PRESERVE-AMI: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL OF INTRACORONARY INFUSION OF AUTOLOGOUS CD34+CELLS IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION POST STEM
    Quyyumi, Arshed
    Kereiakes, Dean
    Shavelle, David
    Henry, Timothy
    Denktas, Ali
    Abdel-Latif, Ahmed
    Toma, Catalin
    Barsness, Gregory
    Frohwein, Stephen
    Schatz, Richard
    Cohen, Martin
    Davidson, Charles
    Dib, Nabil
    Klapholz, Marc
    Schaer, Gary
    Vasquez, Alejandro
    Pecora, Andrew
    Moss, Thomas
    Hyde, Pamela
    Kanakaraj, Anna Maria
    Dich, Le
    Druker, Vitaly
    Junge, Candice
    Preti, Robed
    Losordo, Douglas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1593 - A1593
  • [50] Intracoronary injection of bone marrow derived mononuclear cells, early or late after acute myocardial infarction: Long-term effects on global left ventricular function - Twelve months MRI and long-term clinical results of the SWISS-AMI trial
    Suerder, Daniel
    Manka, Robert
    Turchetto, Lucia
    Moccetti, Tiziano
    Erne, Paul
    Zuber, Michel
    Luescher, Thomas F.
    Windecker, Stephan
    Moschovitis, Aris
    Kozerke, Sebastian
    Corti, Roberto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B45 - B45
12345